Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A new assay to determine oritavancin concentrations.

Vidaillac C, Aeschlimann JR, Rybak MJ.

J Antibiot (Tokyo). 2010 Dec;63(12):717-9. doi: 10.1038/ja.2010.113. Epub 2010 Oct 13. No abstract available.

PMID:
20940724
3.

Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio.

White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA.

Pharmacotherapy. 2003 May;23(5):603-8.

PMID:
12741434
7.
12.

Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Aeschlimann JR, Houlihan HH, Mercier RC, Rybak MJ.

Antimicrob Agents Chemother. 1998 Apr;42(4):981-3.

13.

Efficacy of trovafloxacin against experimental Staphylococcus aureus endocarditis.

Kaatz GW, Seo SM, Aeschlimann JR, Houlihan HH, Mercier RC, Rybak MJ.

Antimicrob Agents Chemother. 1998 Feb;42(2):254-6.

15.

Staphylococcus aureus bacteremia: factors predicting hospital mortality.

Mylotte JM, Aeschlimann JR, Rotella DL.

Infect Control Hosp Epidemiol. 1996 Mar;17(3):165-8.

PMID:
8708354

Supplemental Content

Loading ...
Support Center